SNIP1 Is a Candidate Modifier of the Transcriptional Activity of c-Myc on E Box-Dependent Target Genes

Molecular Cell

Volumn 24, Issue 5, 2006, Pages 771-783

  Fujii, Makiko ^a,c   Lyakh, Lyudmila A ^a   Bracken, Cameron P ^b   Fukuoka, Junya ^a   Hayakawa, Morisada ^c   Tsukiyama, Tadasuke ^d   Soll, Steven J ^a   Harris, Melissa ^a   Rocha, Sonia ^b   Roche, Kevin C ^b   Tominaga, Shin ichi ^c   Jen, Jin ^a   Perkins, Neil D ^b   Lechleider, Robert J ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CELLCYCLE; DNA

Indexed keywords

PROTEIN; SMAD NUCLEAR INTERACTING PROTEIN 1;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; E BOX ELEMENT; EMBRYO; GENE TARGETING; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; ONCOGENE C MYC;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33751505945     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.11.006     Document Type: Article

References (45)

1. Adhikary S., Marinoni F., Hock A., Hulleman E., Popov N., Beier R., Bernard S., Quarto M., Capra M., Goettig S., et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123 (2005) 409-421
2. Amati B. Myc degradation: dancing with ubiquitin ligases. Proc. Natl. Acad. Sci. USA 101 (2004) 8843-8844
3. Amati B., and Vlach J. Kip1 meets SKP2: new links in cell-cycle control. Nat. Cell Biol. 1 (1999) E91-E93
4. Avet-Loiseau H., Gerson F., Magrangeas F., Minvielle S., Harousseau J.L., and Bataille R. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 98 (2001) 3082-3086
5. Bashir T., and Pagano M. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv. Cancer Res. 88 (2003) 101-144
6. Blobel G.A. CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J. Leukoc. Biol. 71 (2002) 545-556
7. Bouchard C., Staller P., and Eilers M.P. Control of cell proliferation by Myc. Trends Cell Biol. 8 (1998) 202-206
8. Boyd K.E., Wells J., Gutman J., Bartley S.M., and Farnham P.J. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl. Acad. Sci. USA 95 (1998) 13887-13892
9. Ciechanover A., DiGiuseppe J.A., Bercovich B., Orian A., Richter J.D., Schwartz A.L., and Brodeur G.M. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88 (1991) 139-143
10. Durocher D., and Jackson S.P. The FHA domain. FEBS Lett. 513 (2002) 58-66
11. Eberhardy S.R., and Farnham P.J. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277 (2002) 40156-40162
12. Faiola F., Liu X., Lo S., Pan S., Zhang K., Lymar E., Farina A., and Martinez E. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 25 (2005) 10220-10234
13. Fukuoka J., Fujii T., Shih J.H., Dracheva T., Meerzaman D., Player A., Hong K., Settnek S., Gupta A., Buetow K., et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin. Cancer Res. 10 (2004) 4314-4324
14. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., and DePinho R.A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18 (1999) 1219-1226
15. Gstaiger M., Jordan R., Lim M., Catzavelos C., Mestan J., Slingerland J., and Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA 98 (2001) 5043-5048
16. Gupta S., Seth A., and Davis R.J. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90 (1993) 3216-3220
17. Hann S.R., and Eisenman R.N. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4 (1984) 2486-2497
18. Kamemura K., Hayes B.K., Comer F.I., and Hart G.W. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277 (2002) 19229-19235
19. Kim R.H., Wang D., Tsang M., Martin J., Huff C., de Caestecker M.P., Parks W.T., Meng X., Lechleider R.J., Wang T., and Roberts A.B. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev. 14 (2000) 1605-1616
20. Kim R.H., Flanders K.C., Birkey R.S., Anderson L.A., Duckett C.S., Perkins N.D., and Roberts A.B. SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional co-activators. J. Biol. Chem. 276 (2001) 46297-46304
21. Kim S.Y., Herbst A., Tworkowski K.A., Salghetti S.E., and Tansey W.P. Skp2 regulates Myc protein stability and activity. Mol. Cell 11 (2003) 1177-1188
22. Land H., Parada L.F., and Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304 (1983) 596-602
23. Land H., Chen A.C., Morgenstern J.P., Parada L.F., and Weinberg R.A. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6 (1986) 1917-1925
24. Lyakh L., Ghosh P., and Rice N.R. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17 (1997) 2475-2484
25. McMahon S.B., Wood M.A., and Cole M.D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20 (2000) 556-562
26. Menssen A., and Hermeking H. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA 99 (2002) 6274-6279
27. Mori K., Maeda Y., Kitaura H., Taira T., Iguchi-Ariga S.M., and Ariga H. MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc. J. Biol. Chem. 273 (1998) 29794-29800
28. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
29. Nikiforov M.A., Chandriani S., Park J., Kotenko I., Matheos D., Johnsson A., McMahon S.B., and Cole M.D. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22 (2002) 5054-5063
30. Oster S.K., Mao D.Y., Kennedy J., and Penn L.Z. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22 (2003) 1998-2010
31. Pal S., Yun R., Datta A., Lacomis L., Erdjument-Bromage H., Kumar J., Tempst P., and Sif S. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol. Cell. Biol. 23 (2003) 7475-7487
32. Pelengaris S., and Khan M. The many faces of c-MYC. Arch. Biochem. Biophys. 416 (2003) 129-136
33. Roche K.C., Wiechens N., Owen-Hughes T., and Perkins N.D. The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene 23 (2004) 8185-8195
34. Sakamuro D., and Prendergast G.C. New Myc-interacting proteins: a second Myc network emerges. Oncogene 18 (1999) 2942-2954
35. Salghetti S.E., Kim S.Y., and Tansey W.P. Destruction of Myc by ubiquitin mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18 (1999) 717-726
36. Schumm K., Rocha S., Caamano J., and Perkins N.D. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO J. 25 (2006) 4820-4832 Published online September 21, 2006
37. Sears R., Leone G., DeGregori J., and Nevins J.R. Ras enhances Myc protein stability. Mol. Cell 3 (1999) 169-179
38. Seoane J., Pouponnot C., Staller P., Schader M., Eilers M., and Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3 (2001) 400-408
39. Shim H., Dolde C., Lewis B.C., Wu C.S., Dang G., Jungmann R.A., Dalla-Favera R., and Dang C.V. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94 (1997) 6658-6663
40. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., and Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59 (1999) 551-557
41. Vervoorts J., and Luscher B. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively. Biol. Chem. 380 (1999) 1121-1126
42. Vervoorts J., Luscher-Firzlaff J.M., Rottmann S., Lilischkis R., Walsemann G., Dohmann K., Austen M., and Luscher B. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4 (2003) 484-490
43. Wanzel M., Herold S., and Eilers M. Transcriptional repression by Myc. Trends Cell Biol. 13 (2003) 146-150
44. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., Ishida N., Okumura F., Nakayama K., and Nakayama K.I. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23 (2004) 2116-2125
45. Zhang H., Kobayashi R., Galaktionov K., and Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82 (1995) 915-925